» Articles » PMID: 12200380

Human Fetuses Are Able to Mount an Adultlike CD8 T-cell Response

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2002 Aug 30
PMID 12200380
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Fetal/neonatal immune responses generally are considered to be immature and weaker than that of adults. We have studied the cord-blood T cells of newborns congenitally infected with Trypanosoma cruzi, the protozoan agent of Chagas disease. Our data demonstrate a predominant activation of CD8 T cells expressing activation markers and armed to mediate effector functions. The analysis of the T-cell receptor beta chain variable repertoire shows the oligoclonal expansion of these T lymphocytes, indicating that activation was driven by parasite antigens. Indeed, we have detected parasite-specific CD8 T cells secreting interferon-gamma after coincubation with live T cruzi. This response is enhanced in the presence of recombinant interleukin-15, which limits the T-cell spontaneous apoptosis. These findings point out that the fetal immune system is more competent than previously appreciated, since fetuses exposed to live pathogens are able to develop an adultlike immune CD8 T-cell response.

Citing Articles

Monocytes from Uninfected Neonates Born to -Infected Mothers Display Upregulated Capacity to Produce TNF-α and to Control Infection in Association with Maternally Transferred Antibodies.

Flores A, Alonso-Vega C, Hermann E, Torrico M, Montano Villarroel N, Torrico F Pathogens. 2023; 12(9).

PMID: 37764911 PMC: 10536721. DOI: 10.3390/pathogens12091103.


Influence of Immune System Abnormalities Caused by Maternal Immune Activation in the Postnatal Period.

Shimizu Y, Sakata-Haga H, Saikawa Y, Hatta T Cells. 2023; 12(5).

PMID: 36899877 PMC: 10001371. DOI: 10.3390/cells12050741.


T-cell receptor variable region usage in Chagas disease: A systematic review of experimental and human studies.

de Souza-Silva T, Gollob K, Dutra W PLoS Negl Trop Dis. 2022; 16(9):e0010546.

PMID: 36107855 PMC: 9477334. DOI: 10.1371/journal.pntd.0010546.


Understanding Early-Life Adaptive Immunity to Guide Interventions for Pediatric Health.

Semmes E, Chen J, Goswami R, Burt T, Permar S, Fouda G Front Immunol. 2021; 11:595297.

PMID: 33552052 PMC: 7858666. DOI: 10.3389/fimmu.2020.595297.


Cyclic Di-Adenosine Monophosphate: A Promising Adjuvant Candidate for the Development of Neonatal Vaccines.

Lirussi D, Weissmann S, Ebensen T, Nitsche-Gloy U, Franz H, Guzman C Pharmaceutics. 2021; 13(2).

PMID: 33535570 PMC: 7912751. DOI: 10.3390/pharmaceutics13020188.